高清福利片

Save Sight Institute

false

Clinical trials

We offer patients emerging treatments for macular diseases.

Browse a list of current, upcoming and previous clinical trials conducted through the Clinical Research Unit.

Enrolling and upcoming clinical trials

Trial Condition Details

Biojiva

(Opening Soon)

Geographic Atrophy (GA)

Find out more (coming soon)

Ethics appoval Bellberry 2025/ETH01765

ADARx

(Opening Soon)

Geographic Atrophy (GA)

Ethics approval SVHM 161/25
Star-MOG (opening soon) Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease

Ethics approval RPAH 2024/ETH02047
Encelto MacTel Type II

Ethics approval SVHM 218/25
Hyperion (opening soon) Leber Congential Amaurosis (LCA)

Ethics approval SVHM 104/25 & SCHN 2025/ETH01223
Therini DME  Diabetic Macular Oedema

Ethics approval Bellberry 2025/ETH00734
Biocryst Diabetic Macular Oedema

Ethics approval Bellberry 2025/ETH00954
KLARITY Central Macular Oedema

Ethics approval  SVHM HREC 309/24
iSight-2 Dry AMD to late Dry AMD

Ethics approval Bellberry 2024/ETH02730
Vantage Non -proliferative Diabetic Retinopathy

Ethical approval SVHM HREC 250/24
BenoBio Wet AMD

Ethical approval Bellberry HREC 2024/ETH01779
RADAR Diabetic Eye Disease Ethical approval HREC/13/SAC/92
MacTel Project MacTel

Ethical approval HREC/16/POWH/215

Current clinical trials

  •  (Dry AMD) - HREC/99641/SVHM-2023-378051
  •  - HREC/70305/SVHM-2021-264245
  •  - HREC/69746/2020-001313-20
  • - HREC 2024/ETH01779
  • - HREC 2025/PID00031 
  • - HREC/230/24
  • - SVHM HREC 310/24
  • - HREC 2024/ETH02730

  •  - HREC/94784/SVHM-2023-358921
  • RADAR - HREC/13/SAC/92
  • 鈥� HREC 2024/PID00308
  • BIOCRYST (DME) - HRE 2025/ETH00954
  • - SESLHD 2025/ETH00492
  • - 2025/ETH00734

  •  鈥� HREC/102954/SVHM-2023-400792(v2)

Completed clinical trials

  •  - HREC/15/RPAH/167
  •  - HREC/13/SHA/46
  •  - HREC/15/RPAH/394
  •  - HREC/14/RPAH/287
  •  - HREC/16/POWH/543
  •  - HREC/15/RPAH/347
  •  - HREC/15/RPAH/387
  •  - HREC/53858/SVHM-2019
  •  - HREC/18/SVHM/251
  •  - HREC/49517/SVHM-2019
  •  - HREC/18/SVHM/252
  •  - HREC/70671/SVHM-2021-263810 
  •  - HREC/67626/SVHM-2020-232811
  •  - SVHM HREC 294/20
  •  - HREC/72069/SVHM-2020-244368
  •  - CALHN HREC 2021/HRE00112 
  •  - HREC/50571/SVHM-2018 
  •  - HREC/52072/SVHM-2019 
  • PULSAR (Wet AMD) and PULSAR Ext (Wet AMD) - HREC/63698/SVHM-2020-213156
  • - HREC/103832/SVHM-2023-400811
  • - HREC/77051/SVHM-2021-273676

  •  - HREC/17/POWH/178
  •  - HREC/18/MH/103
  •  - HREC/51264/SVHM-2019
  •  - HREC/67565/SVHM-2020-226369
  •  - HREC/65076/SVHM-2020-230166
  •  - HREC/65387/SVHM-2020-219227
  •  - HREC/61973/SVHM-2020
  • - HREC/97356/SVHM-2023-36744

  •  - HREC/16/RAH/250
  •  - HREC/12/RPAH/547
  • Genetic study of Diabetic Retinopathy - SESLHD HREC 08/213
  •  - HREC/14/RPAH/205
  •  - LNR/17/POWH/619
  •  - HREC/14/RPAH/204
  •  - HREC/18/SVHM/149
  •  - HREC/18/SVHM/240
  •  - HREC/67565/SVHM-2020-226369
  •  - Bellberry HREC 2020/ETH02613
  •  - HREC/63535/SVHM-2020
  •  - HREC/68388/SVHM-2020-230633
  • -  HREC/103584/SVHM-2023 

  •  - HREC/13/RPAH/393
  •  - SCGOPHCG HREC  RGS0000004826
  •  - HREC/17/SVHM/192

  • - Ethical approval HREC/101598/SVHM-2023

Patient feedback

"I was so happy with the whole team's service and with how kind everyone was at every visit. It felt like family and 'home'. "

鈥淚 feel very honoured to be part of clinical trials helping find new medications for future patients...the research team provides a very high level of service to the patients involved.鈥�

鈥淢y experience with the clinical trials team has been very good and I am very appreciative of the support that I received throughout my time with them.鈥�

Hear more from our patients .